1. Home
  2. BIAF vs CREV Comparison

BIAF vs CREV Comparison

Compare BIAF & CREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • CREV
  • Stock Information
  • Founded
  • BIAF 2014
  • CREV 2007
  • Country
  • BIAF United States
  • CREV Australia
  • Employees
  • BIAF N/A
  • CREV N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CREV
  • Sector
  • BIAF Health Care
  • CREV
  • Exchange
  • BIAF Nasdaq
  • CREV Nasdaq
  • Market Cap
  • BIAF 6.7M
  • CREV 7.0M
  • IPO Year
  • BIAF 2022
  • CREV N/A
  • Fundamental
  • Price
  • BIAF $1.59
  • CREV $2.69
  • Analyst Decision
  • BIAF Hold
  • CREV
  • Analyst Count
  • BIAF 1
  • CREV 0
  • Target Price
  • BIAF N/A
  • CREV N/A
  • AVG Volume (30 Days)
  • BIAF 175.0K
  • CREV 106.0K
  • Earning Date
  • BIAF 11-14-2025
  • CREV 01-01-0001
  • Dividend Yield
  • BIAF N/A
  • CREV N/A
  • EPS Growth
  • BIAF N/A
  • CREV N/A
  • EPS
  • BIAF N/A
  • CREV N/A
  • Revenue
  • BIAF $6,776,739.00
  • CREV $47,677,475.00
  • Revenue This Year
  • BIAF N/A
  • CREV $40.32
  • Revenue Next Year
  • BIAF $20.04
  • CREV N/A
  • P/E Ratio
  • BIAF N/A
  • CREV N/A
  • Revenue Growth
  • BIAF N/A
  • CREV 86.77
  • 52 Week Low
  • BIAF $1.52
  • CREV $2.00
  • 52 Week High
  • BIAF $46.53
  • CREV $12.75
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 34.93
  • CREV 32.77
  • Support Level
  • BIAF $1.91
  • CREV $2.33
  • Resistance Level
  • BIAF $2.25
  • CREV $4.58
  • Average True Range (ATR)
  • BIAF 0.20
  • CREV 0.61
  • MACD
  • BIAF -0.06
  • CREV -0.26
  • Stochastic Oscillator
  • BIAF 6.54
  • CREV 8.43

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About CREV Carbon Revolution Public Limited

Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.

Share on Social Networks: